18F-labeled FGFR1 peptide: a new PET probe for subtype FGFR1 receptor imaging
IntroductionThe fibroblast growth factor receptor (FGFR) family is highly expressed in a variety of tumor types and represents a new target for cancer therapy. Different FGFR subtype aberrations have been found to exhibit highly variable sensitivity and efficacy to FGFR inhibitors.MethodsThe present...
Main Authors: | Yang Chen, Jingya Han, Yan Zhao, Xinming Zhao, Mengmeng Zhao, Jingmian Zhang, Jianfang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1047080/full |
Similar Items
-
Biological Significance and Targeting of the FGFR Axis in Cancer
by: Athina-Myrto Chioni, et al.
Published: (2021-11-01) -
FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
by: Joanna Moes-Sosnowska, et al.
Published: (2022-09-01) -
FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention
by: Antonella De Luca, et al.
Published: (2020-09-01) -
Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity
by: Gregor Vlacic, et al.
Published: (2019-09-01) -
Novel <i>FGFR1</i> Variants Are Associated with Congenital Scoliosis
by: Shengru Wang, et al.
Published: (2021-07-01)